Trials / Completed
CompletedNCT00362674
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
An Open-label, Observation Study to Evaluate the Durability of Antiviral Activity in Chronic Hepatitis B Patients Who Showed Complete Response in L-FMAU-301,L-FMAU-302 or L-FMAU-303 Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Bukwang Pharmaceutical · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the durability of antiviral activity in chronic hepatitis B patients who showed complete response in L-FMAU-301,L-FMAU-302 or L-FMAU-303 trial.
Conditions
Timeline
- Start date
- 2005-06-01
- First posted
- 2006-08-10
- Last updated
- 2017-02-01
Locations
27 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00362674. Inclusion in this directory is not an endorsement.